Prevalence and mechanisms of ciprofloxacin resistance in Escherichia coli isolated from hospitalized patients, healthy carriers, and wastewaters in Iran.

Neyestani, Zohreh; Khademi, Farzad; Teimourpour, Roghayeh; Amani, Mojtaba; Arzanlou, Mohsen

Neyestani, Zohreh; Khademi, Farzad; Teimourpour, Roghayeh; Amani, Mojtaba; Arzanlou, Mohsen.

Afiliação

Neyestani Z; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Khademi F; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Teimourpour R; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Amani M; Department of Medicinal Chemistry, Faculty of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
Arzanlou M; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. m.arzanlou@arums.ac.ir.

BMC Microbiol ; 23(1): 191, 2023 07 17.

Article em En | MEDLINE | ID: mdl-37460988

Assuntos

Ciprofloxacina; Quinolonas; Criança; Humanos; Ciprofloxacina/farmacologia; Escherichia coli; Águas Residuárias; Antibacterianos/farmacologia; Prevalência; Irã (Geográfico)/epidemiologia; Farmacorresistência Bacteriana/genética; Quinolonas/farmacologia; DNA Girase/genética; Testes de Sensibilidade Microbiana

Palavras-chave

Antibiotic resistance; Ciprofloxacin; Escherichia coli; Healthy carriers; PMQR; Patients; QRDR; Wastewater

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ciprofloxacina / Quinolonas Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Asia Idioma: En Revista: BMC Microbiol Assunto da revista: MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google